Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumors × adavosertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 4 Advanced Solid Tumours 4 Small Cell Lung Carcinoma 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Fallopian Tube Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Lung Neoplasms 2 Advanced Malignant Solid Neoplasm 2 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple-negative Metastatic Breast Cancer 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Muscle Invasive Bladder Cancer 1 Multiple Myeloma 1

Interventions

Paclitaxel 13 Gemcitabine 10 pembrolizumab 8 atezolizumab 8 Carboplatin 8 Irinotecan 7 Docetaxel 7 Bevacizumab 7 Cetuximab 6 Sunitinib 5 Leucovorin 5 Injections 5 Fluorouracil 5 Cyclophosphamide 5 Capecitabine 5 olaparib 4 navitoclax 4 liposomal doxorubicin 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 spartalizumab 3 lenvatinib 3 fludarabine 3 Cisplatin 3 zolbetuximab 2 tocilizumab 2 tivozanib 2 tislelizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00648648 2023-09-21

MK-1775-001

Merck Sharp & Dohme LLC

Phase 1 Completed

206 enrolled 40 charts

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡